Table 3.
Protein Expression of the Serum Biomarkers of TSA, AGP, CC16 and HDL-C in the Sera of Participants with and Without COPD
| Men | Women | |||||||
|---|---|---|---|---|---|---|---|---|
| Non-COPD | GOLD-1 | COPD GOLD-2 | GOLD-3 and 4 | Non-COPD | GOLD-1 | COPD GOLD-2 | GOLD-3 and 4 | |
| TSA (mg/dl) | 51.4 ± 3.6 | 52.5 ± 2.1 | 57.4 ± 3.8*,# | 60.1 ± 3.4*,# | 51.1 ± 3.1 | 51.6 ± 2.6 | 55 ± 3.8*,# | 57 ± 3.3*,# |
| AGP (g/l)> | 0.794 ± 0.04 | 0.743 ± 0.07 | 0.936 ± 0.04 | 0.963 ± 0.05# | 0.813 ± 0.05 | 0.846 ± 0.07 | 0.833 ± 0.06 | 0.783 ± 0.05 |
| CC16 (ng/mL) | 23.53 ± 3.2 | 21.66 ± 4.13 | 16.7 ± 3.51*,# | 12.05 ± 2.09*,# | 24.68 ± 4.06 | 21.33 ± 3.71 | 17.36 ± 2.82*,# | 15.15 ± 2.94*,# |
| HDL-C (mg/dl) | 42.92 ± 2.34 | 41.96 ± 1.97 | 39.36 ± 3.46 | 31.71 ± 3.65*,#,φ | 41.68 ± 3.18 | 40.27 ± 3.21 | 37.26 ± 2.14 | 34.21 ± 3.24*,# |
Notes: Values are Expressed as Mean ± SD; One-Way Analysis of Variance. *p < 0.05 Vs Non-COPD Group of the Same Gender; #p < 0.05 Vs GOLD-1 Subgroup of the Same Gender; φp < 0.05 Vs GOLD-2 Subgroup of the Same Gender.